GENFIT Announces Upcoming Shareholders Meeting
Company Announcements

GENFIT Announces Upcoming Shareholders Meeting

Genfit (GNFT) has released an update.

GENFIT, a biopharmaceutical company focusing on severe liver diseases, has announced its upcoming Combined Shareholders Meeting scheduled for May 22, 2024. Shareholders will have access to the meeting’s documents on the company’s website and can submit their votes via the VOTACCESS platform. GENFIT, known for its extensive work in liver disease research, has a diverse pipeline with programs in various development stages.

For further insights into GNFT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskGenfit’s Iqirvo Wins EU Approval for Liver Condition
TipRanks Auto-Generated NewsdeskGENFIT SA Showcases Robust 2024 Financial Health
TipRanks Auto-Generated NewsdeskGenfit SA Expands R&D, Gains FDA Approval
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App